| Completed | A Study Utilizing Patient-Reported Outcomes to Evaluate the Safety and Efficacy of Lorecivivint (SM04690) for Knee Osteoarthritis | Phase 3 | 2022-11-18 |
| Terminated | A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combi Castration-resistant Prostate Cancer, Non-small Cell Lung Cancer, Colorectal Cancer | Phase 1 | 2021-11-03 |
| Terminated | 3-year, Open-Label Study Evaluating Safety, Tolerability, and Efficacy of Lorecivivint in Knee Osteoarthritis Osteoarthritis of the Knee | Phase 3 | 2021-07-15 |
| Completed | Drug-Drug Interaction Study of Lorecivivint and Triamcinolone Acetonide in Healthy Volunteers Drug-Drug Interaction | Phase 1 | 2020-10-13 |
| Terminated | A Long-Term Safety and Efficacy Study of Lorecivivint in Subjects With Osteoarthritis of the Knee Osteoarthritis, Knee | Phase 3 | 2020-08-25 |
| Completed | Patient-Reported Outcomes in Evaluating Lorecivivint (SM04690) for Moderate to Severe Knee Osteoarthritis (STR Knee Osteoarthritis | Phase 3 | 2020-05-26 |
| Completed | Patient-Reported and Radiographic Outcomes in Evaluating Lorecivivint (SM04690) for the Treatment of Knee Oste Knee Osteoarthritis | Phase 3 | 2019-05-17 |
| Terminated | MRI Study to Evaluate the Safety and Efficacy of SM04690 for Knee Osteoarthritis Knee Osteoarthritis | Phase 2 | 2019-03-11 |
| Completed | Safety and Bone Health Study of SM04690 for the Treatment of Moderately to Severely Symptomatic Knee Osteoarth Knee Osteoarthritis | Phase 2 | 2018-11-28 |
| Completed | A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alop Androgenetic Alopecia | Phase 2 / Phase 3 | 2018-11-01 |
| Terminated | A Study Evaluating the Safety and Pharmacokinetics of Orally Administered SM08502 in Subjects With Advanced So Solid Tumor, Adult | Phase 1 | 2017-11-06 |
| Completed | A Repeat Insult Patch Test (RIPT) Study Evaluating the Sensitization Potential of Topical SM04755 Solution in Tendinopathy | Phase 1 | 2017-09-11 |
| Terminated | A Study of the Safety, Tolerability, and Pharmacokinetics of SM04690 Injectable Suspension Following Single In Degenerative Disc Disease | Phase 1 | 2017-07-26 |
| Completed | A Study Evaluating the Safety and Efficacy of SM04690 for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis | Phase 2 | 2017-04-24 |
| Completed | A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of SM04755 Follo Tendinopathy | Phase 1 | 2016-11-03 |
| Completed | An Observational Study Evaluating the Safety, Tolerability, and Efficacy of Treatment of SM04690 or Placebo Pr Osteoarthritis | — | 2016-09-19 |
| Completed | A Study Evaluating the Safety, Tolerability, and Efficacy of SM04690 Injected in the Target Knee Joint of Mode Osteoarthritis | Phase 2 | 2015-09-09 |
| Completed | A Study of SM04554 Applied Topically to the Scalp of Male Subjects With Androgenetic Alopecia Analyzed by Biop Androgenetic Alopecia | Phase 2 | 2015-08-01 |
| Completed | A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenet Androgenetic Alopecia | Phase 2 | 2014-11-01 |
| Completed | Safety and Pharmacokinetics of SM04755 in Subjects With Advanced Colorectal, Gastric, Hepatic, or Pancreatic C Colorectal Cancer, Gastric Cancer, Hepatic Cancer | Phase 1 | 2014-06-19 |
| Completed | Phase 1, Dose Escalation Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of S Moderate to Severe Osteoarthritis | Phase 1 | 2014-03-01 |
| Withdrawn | A Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of SM04646 Inhalation Solution Idiopathic Pulmonary Fibrosis | Phase 2 | 1900-01-01 |